Cubist Systematic Strategies’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,512
Closed -$25.3K 4778
2022
Q4
$25.3K Sell
1,512
-39,166
-96% -$662K ﹤0.01% 3977
2022
Q3
$698K Sell
40,678
-208,548
-84% -$3.27M ﹤0.01% 2908
2022
Q2
$1.95M Sell
249,226
-168,596
-40% -$1.45M 0.01% 1893
2022
Q1
$4.63M Buy
417,822
+26,528
+7% +$297K 0.04% 785
2021
Q4
$6.88M Sell
391,294
-168,578
-30% -$3.27M 0.07% 449
2021
Q3
$11.3M Buy
559,872
+223,383
+66% +$5.74M 0.14% 155
2021
Q2
$11.1M Buy
336,489
+177,291
+111% +$6.69M 0.13% 172
2021
Q1
$6.22M Buy
159,198
+139,381
+703% +$6.54M 0.08% 343
2020
Q4
$865K Buy
19,817
+54
+0.3% +$1.84K 0.01% 1473
2020
Q3
$560K Buy
+19,763
New +$624K 0.01% 1683

Cubist Systematic Strategies's ONEM Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,512 shares — an estimated $25.3K sold.

Cubist Systematic Strategies first reported a position in ONEM in Q3 2020 and held it in 10 quarters. The position peaked at $11.3M in Q3 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Cubist Systematic Strategies reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,512 1Life Healthcare shares in Q1 2023, an estimated $25.3K.
  • Cubist Systematic Strategies first reported a position in 1Life Healthcare in Q3 2020 and held it in 10 quarters.
  • Cubist Systematic Strategies's 1Life Healthcare position peaked at $11.3M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.